Accessing GLP-1 treatment in Pleasanton, California has traditionally meant longer waits than mainland patients face. Ozempic® is the FDA-approved Injectable pen Semaglutide product by Novo Nordisk. Weight Method's telehealth model is a separate program built for distance: licensed providers evaluate eligibility, and compounded Semaglutide (dispensed by a U.S.-licensed 503A pharmacy) ships to any Pleasanton address at $199/month. Compounded Semaglutide is not FDA-approved.
FDA-approved Ozempic prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Pleasanton is already seeing results
Ozempic in Pleasanton, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Ozempic to patients in Pleasanton from $199/month with virtual consultations and direct-to-door shipping.
Ozempic® by Novo Nordisk is the FDA-approved Injectable pen Semaglutide product, taken Once weekly and approved in 2017 for Type 2 diabetes. Semaglutide works by mimicking incretin hormones that regulate hunger and satiety, reducing appetite and helping you feel full with smaller portions. Weight Method is a separate telehealth program for Pleasanton residents: licensed providers evaluate eligible patients and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program starts at $199/month and includes the provider evaluation, the medication, ongoing care, and home delivery.
Research suggests Semaglutide therapy is studied across diverse populations, and outcomes can improve when care is culturally informed. In Pleasanton, Weight Method pairs compounded Semaglutide treatment (dispensed by a U.S.-licensed 503A pharmacy; compounded Semaglutide is not FDA-approved) with bilingual support that respects cultural context, from dietary guidance that accounts for traditional foods to communication in the language you are most comfortable with. The program starts at $199/month.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in California and start Ozempic from $199/month.
Get Started NowFree consultation. No commitment.